公开(公告)号：US20230346888A1

公开(公告)日：2023-11-02

申请号：US18140535

申请日：2023-04-27

Applicant: AINOS INC. TAIWAN BRANCH (USA)

Inventor： Tsung-Fu YU ,  Chun-Hsien TSAI ,  Ting-Chuan LEE ,  Chun-Jung TSAI

IPC: A61K38/21 ,  A61K9/00 ,  A61K45/06 ,  A61P31/14

CPC classification number: A61K38/212 ,  A61K9/006 ,  A61K45/06 ,  A61P31/14

Abstract: The present application provides a method for treating and/or preventing an infection of Coronavirus comprising: providing a therapeutically effective amount of a composition comprising interferon to a subject via sublingual administration and/or buccal administration; wherein the Coronavirus comprises SARS-CoV-2.

公开(公告)号：US20240408178A1

公开(公告)日：2024-12-12

申请号：US18731677

申请日：2024-06-03

Applicant: Ainos, Inc.

Inventor： Tsung-Fu YU ,  Chun-Hsien TSAI ,  Ting-Chuan LEE

IPC: A61K38/21 ,  A61K9/00

Abstract: Provided is a low-dose interferon composition for treatment or prevention of conditions, diseases or disorders associated with inflammation in cat. The composition comprises a total concentration of human interferon-α2b in a range of 160 IU/ml to 100,000 IU/ml. The composition is orally administered buccally.

公开(公告)号：US20240398901A1

公开(公告)日：2024-12-05

申请号：US18733102

申请日：2024-06-04

Applicant: AINOS INC. TAIWAN BRANCH (USA)

Inventor： Tsung-Fu YU ,  Yi-Yu TIEN ,  Chun-Hsien TSAI ,  Ting-Chuan LEE ,  Chun-Jung TSAI

IPC: A61K38/21 ,  A61K9/20

Abstract: The present application provides a process for manufacturing an orally disintegrating tablet (ODT) comprising a cytokine as an active pharmaceutical ingredient comprising: acidifying an excipient, conducting a first granulation step of the acidified excipient to obtain acidic powders, and conducting a second granulation step by mixing the acidic powders and the cytokine to obtain granules containing the cytokine. The present application also provides an ODT manufactured by the process.